Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Berthold

Showing results (151-160 of 162) with videos related to

Pageof 17
Sort By:
Nutrition Journal|August 25, 2017
Randomized supplementation of 4000 IU vitamin D<sub>3</sub> daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trialJ B Ernst, S Prokop, U Fuchs, et al.
European Journal of Pediatrics|August 1, 1997
Integration of amino acid and carbon intermediary metabolism: studies with uniformly labeled tracers and mass isotopomer analysisP J Reeds, H K Berthold, J J Boza, et al.
European Journal of Nutrition|March 17, 2018
Vitamin D supplementation does not prevent the testosterone decline in males with advanced heart failure: the EVITA trialArmin Zittermann, Jana B Ernst, Sylvana Prokop, et al.
Annals of Nutrition & Metabolism|December 17, 2018
Daily Supplementation with 4000 IU Vitamin D3 for Three Years Does Not Modify Cardiovascular Risk Markers in Patients with Advanced Heart Failure: The Effect of Vitamin D on Mortality in Heart Failure TrialArmin Zittermann, Jana B Ernst, Sylvana Prokop, et al.
Journal of Interventional Cardiology|October 18, 2003
Comparison of a silicon carbide coated stent versus a noncoated stent in humans: the Tenax- versus Nir-Stent Study (TENISS)Martin Unverdorben, Katherine Sattler, Ralf Degenhardt, et al.
Atherosclerosis|November 6, 2007
Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy menIoanna Gouni-Berthold, Heiner K Berthold, Helena Gylling, et al.
International Journal of Cardiology|January 19, 2019
Vitamin D supplementation of 4000 IU daily and cardiac function in patients with advanced heart failure: The EVITA trialA Zittermann, J B Ernst, S Prokop, et al.
Journal of Lipid Research|February 26, 2015
IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humansNike Müller, Dominik M Schulte, Kathrin Türk, et al.
American Heart Journal|April 8, 2003
Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: the Tenax versus Nir Stent Study's long-term outcomeMartin Unverdorben, Babett Sippel, Ralf Degenhardt, et al.
European Heart Journal|May 13, 2017
Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D dailyArmin Zittermann, Jana B Ernst, Sylvana Prokop, et al.
Pageof 17

Showing results (151-160 of 162) with videos related to

Sort By:
Pageof 17
Nutrition Journal|August 25, 2017
Randomized supplementation of 4000 IU vitamin D<sub>3</sub> daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trialJ B Ernst, S Prokop, U Fuchs, et al.
European Journal of Pediatrics|August 1, 1997
Integration of amino acid and carbon intermediary metabolism: studies with uniformly labeled tracers and mass isotopomer analysisP J Reeds, H K Berthold, J J Boza, et al.
European Journal of Nutrition|March 17, 2018
Vitamin D supplementation does not prevent the testosterone decline in males with advanced heart failure: the EVITA trialArmin Zittermann, Jana B Ernst, Sylvana Prokop, et al.
Annals of Nutrition & Metabolism|December 17, 2018
Daily Supplementation with 4000 IU Vitamin D3 for Three Years Does Not Modify Cardiovascular Risk Markers in Patients with Advanced Heart Failure: The Effect of Vitamin D on Mortality in Heart Failure TrialArmin Zittermann, Jana B Ernst, Sylvana Prokop, et al.
Journal of Interventional Cardiology|October 18, 2003
Comparison of a silicon carbide coated stent versus a noncoated stent in humans: the Tenax- versus Nir-Stent Study (TENISS)Martin Unverdorben, Katherine Sattler, Ralf Degenhardt, et al.
Atherosclerosis|November 6, 2007
Effects of ezetimibe and/or simvastatin on LDL receptor protein expression and on LDL receptor and HMG-CoA reductase gene expression: a randomized trial in healthy menIoanna Gouni-Berthold, Heiner K Berthold, Helena Gylling, et al.
International Journal of Cardiology|January 19, 2019
Vitamin D supplementation of 4000 IU daily and cardiac function in patients with advanced heart failure: The EVITA trialA Zittermann, J B Ernst, S Prokop, et al.
Journal of Lipid Research|February 26, 2015
IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humansNike Müller, Dominik M Schulte, Kathrin Türk, et al.
American Heart Journal|April 8, 2003
Comparison of a silicon carbide-coated stent versus a noncoated stent in human beings: the Tenax versus Nir Stent Study's long-term outcomeMartin Unverdorben, Babett Sippel, Ralf Degenhardt, et al.
European Heart Journal|May 13, 2017
Effect of vitamin D on all-cause mortality in heart failure (EVITA): a 3-year randomized clinical trial with 4000 IU vitamin D dailyArmin Zittermann, Jana B Ernst, Sylvana Prokop, et al.
Pageof 17